ARTA: AT1-receptor blocker therapy in patients undergoing coronary artery bypass grafting

Clinical Research in Cardiology

Volumn 98, Issue 1, 2009, Pages 33-43

  Flesch, Markus ^a   Knipp, Stephan ^b   Kessler, Gerhard ^a   Geissler, Hans Joachim ^a   Massoudy, Parwis ^b   Wilhelm, Hans ^b   Philipp, Thomas ^b   Erdmann, Erland ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Angiotensin II; AT1 blockade; CABG surgery; Neurocognitive function; Renal failure

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; CANDESARTAN; PLACEBO; ANGIOTENSIN RECEPTOR ANTAGONIST; BENZIMIDAZOLE DERIVATIVE; CREATININE; TETRAZOLE DERIVATIVE;

AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CREATININE CLEARANCE; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HYPERTENSION; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MEMORY CONSOLIDATION; PREOPERATIVE PERIOD; PSYCHOLOGIC ASSESSMENT; PSYCHOLOGIC TEST; RANDOMIZED CONTROLLED TRIAL; RENAL REPLACEMENT THERAPY; TASK PERFORMANCE; UNSPECIFIED SIDE EFFECT; BLOOD; BLOOD PRESSURE; COGNITIVE DEFECT; DRUG EFFECT; POSTOPERATIVE COMPLICATION; PREOPERATIVE CARE; PROSPECTIVE STUDY; URINE;

AGED; AGED, 80 AND OVER; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; BENZIMIDAZOLES; BLOOD PRESSURE; COGNITION DISORDERS; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; CREATININE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERTENSION; KIDNEY FAILURE; MALE; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; PROSPECTIVE STUDIES; TETRAZOLES;

EID: 58849084979     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-008-0719-9     Document Type: Article

References (25)

1. M Boodhwani FD Rubens D Wozny R Rodriguez A Alsefaou PJ Hendry HJ Nathan 2006 Predictors of early neurocognitive deficits in low-risk patients undergoing on-pump coronary artery bypass surgery Circulation 114 I461 I466
2. BM Brenner ME Cooper D de Zeeuw WF Keane WE Mitch HH Parving G Remuzzi SM Snapinn Z Zhang S Shahinfar 2001 Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy N Engl J Med 345 861 869
3. JD Coyle SF Gardner CM White 2004 The renal protective effects of angiotensin II receptor blockers in type 2 diabetes mellitus Ann Pharmacother 38 1731 1738
4. B Dahlof RB Devereux SE Kjeldsen S Julius G Beevers U de Faire F Fyhrquist H Ibsen K Kristiansson O Lederballe-Pedersen LH Lindholm MS Nieminen P Omvik S Oparil H Wedel 2002 Cardiovascular morbidity and mortality in the losartan intervention for endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol Lancet 359 995 1003
5. G Dupuis E Kennedy R Lindquist FB Barton ML Terrin BJ Hoogwerf SM Czajkowski JA Herd 2006 Coronary artery bypass graft surgery and cognitive performance Am J Crit Care 15 471 478
6. Y Inada T Wada M Ojima T Sanada Y Shibouta R Kanagawa Y Ishimura Y Fujisawa K Nishikawa 1997 Protective effects of candesartan cilexetil (TCV-116) against stroke, kidney dysfunction and cardiac hypertrophy in stroke-prone spontaneously hypertensive rats Clin Exp Hypertens 19 1079 1099
7. T Ito H Yamakawa C Bregonzio JA Terron A Falcon-Neri JM Saavedra 2002 Protection against ischemia and improvement of cerebral blood flow in genetically hypertensive rats by chronic pretreatment with an angiotensin II AT1 antagonist Stroke 33 2297 2303
8. BO Jensen P Hughes LS Rasmussen PU Pedersen DA Steinbruchel 2006 Cognitive outcomes in elderly high-risk patients after off-pump versus conventional coronary artery bypass grafting: a randomized trial Circulation 113 2790 2795
9. SC Knipp N Matatko H Wilhelm M Schlamann P Massoudy M Forsting HC Diener H Jakob 2004 Evaluation of brain injury after coronary artery bypass grafting. A prospective study using neuropsychological assessment and diffusion-weighted magnetic resonance imaging Eur J Cardiothorac Surg 25 791 800
10. PB Leurs AW Mulder HA Fiers SJ Hoorntje 1989 Acute renal failure after cardiovascular surgery. Current concepts in pathophysiology, prevention and treatment Eur Heart J 10 Suppl H 38 42
11. EJ Lewis LG Hunsicker WR Clarke T Berl MA Pohl JB Lewis E Ritz RC Atkins R Rohde I Raz 2001 Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes N Engl J Med 345 851 860
12. H Lithell L Hansson I Skoog D Elmfeldt A Hofman B Olofsson P Trenkwalder A Zanchetti 2003 The study on cognition and prognosis in the elderly (SCOPE): principal results of a randomized double-blind intervention trial J Hypertens 21 875 886
13. CE Mogensen S Neldam I Tikkanen S Oren R Viskoper RW Watts ME Cooper 2000 Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study BMJ 321 1440 1444
14. BD Myers M Hilberman BJ Carrie RJ Spencer EB Stinson CR Robertson 1981 Dynamics of glomerular ultrafiltration following open-heart surgery Kidney Int 20 366 374
15. M Newman ND Croughwell JA Blumenthal WD White JB Lewis LR Smith P Frasco EA Towner RM Schell BJ Hurwitz 1994 Effect of aging on cerebral autoregulation during cardiopulmonary bapass: association with postoperative cognitive dysfunction Circulation 90 Suppl II II243 II249
16. MF Newman ND Croughwell JA Blumenthal E Lowry WD White W Spillane RD Davis Jr DD Glower LR Smith EP Mahanna 1995 Predictors of cognitive decline after cardiac operation Ann Thorac Surg 59 1326 1330
17. MF Newman JL Kirchner B Phillips-Bute V Gaver H Grocott RH Jones DB Mark JG Reves JA Blumenthal 2001 Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery N Engl J Med. 344 395 402
18. Y Nishimura T Ito JM Saavedra 2000 Angiotensin II AT(1) blockade normalizes cerebrovascular autoregulation and reduces cerebral ischemia in spontaneously hypertensive rats Stroke 31 2478 2486
19. SS Panesar T Athanasiou S Nair C Rao C Jones M Nicolaou A Darzi 2006 Early outcomes in the elderly: a meta-analysis of 4,921 patients undergoing coronary artery bypass grafting-comparison between off-pump and on-pump techniques Heart 92 1808 1816
20. HH Parving H Lehnert J Brochner-Mortensen R Gomis S Andersen P Arner 2001 The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes N Engl J Med 345 870 878
21. GW Roach M Kanchuger CM Mangano M Newman N Nussmeier R Wolman A Aggarwal K Marschall SH Graham C Ley 1996 Adverse cerebral outcomes after coronary bypass surgery. Multicenter study of perioperative ischemia research group and the ischemia research and education foundation investigators N Engl J Med 335 1857 1863
22. PJ Shaw D Bates NE Cartlidge JM French D Heaviside DG Julian DA Shaw 1987 Neurologic and neuropsychological morbidity following major surgery: comparison of coronary artery bypass and peripheral vascular surgery Stroke 18 700 707
23. KA Sotaniemi 1995 Long-term neurologic outcome after cardiac operation Ann Thorac Surg 59 1336 1339
24. T Vraamark G Waldemar S Strandgaard OB Paulson 1995 Angiotensin II receptor antagonist CV-11974 and cerebral blood flow autoregulation J Hypertens 13 755 761
25. C Werner M Baumhakel KK Teo R Schmieder J Mann T Unger S Yusuf M Bohm 2008 RAS blockade with ARB and ACE inhibitors: current perspective on rationale and patient selection Clin Res Cardiol 97 418 431